TEST BANK - Clayton’s Basic Pharmacology for Nurses 19th Edition Michelle Willihnganz, All Chapters 1 - 48, Newest Version | Complete Solution Guide.

TEST BANK FOR CLAYTON’S BASIC PHARMACOLOGY FOR
NURSES 19TH EDITION BY MICHELLE WILLIHNGANZ |
COMPLETE CHAPTERS 1-48 | 100%VERIFIED

Chapter 1: Drug Definitions, Standards, and Information Sources
vi vi vi vi vi vi vi




Test Bank
vi vi




MULTIPLE CHOICE vi




1. What is the name under which a drug is listed by the U.S. Food and Drug Administration
vi vi vi vi vi vi vi vi vi vi vi vi vi vi vi vi



vi (FDA)?
a. Brand
b. Nonproprietary
c. Official
d. Trademark
ANS: v i C
The official name is the name under which a drug is listed by the FDA. The brand name, or
vi vi vi vi vi vi vi vi vi vi vi vi vi vi vi vi vi vi



trademark, is the name given to a drug by its manufacturer. The nonproprietary, or generic,
vi vi vi vi vi vi vi vi vi vi vi vi vi vi vi



name is provided by the U.S. Adopted Names Council.
vi vi vi vi vi vi vi vi vi




DIF: Cognitive Level: Knowledge REF: p. 1 OBJ: vi vi v i vi



v 2 TOP: Nursing Process Step: Assessment
i vi v i vi vi vi



MSC: NCLEX Client Needs Category: Safe, Effective Care Environment
v i vi vi vi vi vi vi vi




2. Which source contains information specific to nutritional supplements?
vi vi vi vi vi vi vi



a. USP Dictionary of USAN & International Drug Names
vi vi vi vi vi vi vi



b. Natural Medicines Comprehensive Database vi vi vi



c. United States Pharmacopoeia/National Formulary (USP NF) vi vi vi vi vi



d. Drug Interaction Facts vi vi




ANS: v i C
United States Pharmacopoeia/National Formulary contains information specific to nutritional
vi vi vi vi vi vi vi vi



supplements. USP Dictionary of USAN & International Drug Names is a compilation of drug
vi vi vi vi vi vi vi vi vi vi vi vi vi vi



names, pronunciation guide, and possible future FDA approved drugs; it does not include
vi vi vi vi vi vi vi vi vi vi vi vi vi



nutritional supplements. Natural Medicines Comprehensive Database contains evidence based
vi vi vi vi vi vi vi vi vi



information on herbal medicines and herbal combination products; it does not include
vi vi vi vi vi vi vi vi vi vi vi vi



information specific to nutritional supplements. Drug Interaction Facts contains
vi vi vi vi vi vi vi vi vi



comprehensive information on drug interaction facts; it does not include nutritional
vi vi vi vi vi vi vi vi vi vi vi



supplements.
vi




DIF: Cognitive Level: Knowledge REF: p. 2 OBJ: vi vi v i vi



v 4 TOP: Nursing Process Step: Assessment
i vi v i vi vi vi



MSC: NCLEX Client Needs Category: Physiological Integrity
v i vi vi vi vi vi




3. What is the most comprehensive reference available to research a drug interaction?
vi vi vi vi vi vi vi vi vi vi vi



a. Drug Facts and Comparisons vi vi vi



b. Drug Interaction Facts vi vi



c. Handbook on Injectable Drugs vi vi vi



d. Martindale—The Complete Drug Reference vi vi vi




ANS: v i B

, First published in 1983, Drug Interaction Facts is the most comprehensive book available on
vi vi vi vi vi vi vi vi vi vi vi vi vi



drug interactions. In addition to monographs listing various aspects of drug interactions, this
vi vi vi vi vi vi vi vi vi vi vi vi vi



information is reviewed and updated by an internationally renowned group of physicians and
vi vi vi vi vi vi vi vi vi vi vi vi vi



pharmacists with clinical and scientific expertise.
vi vi vi vi vi vi




DIF: Cognitive Level: Comprehension REF: p. 3 OBJ: vi vi v i vi



v 3 TOP: Nursing Process Step: Assessment
i vi v i vi vi vi



MSC: NCLEX Client Needs Category: Physiological Integrity
v i vi vi vi vi vi




4. The physician has written an order for a drug with which the nurse is unfamiliar. Which
vi vi vi vi vi vi vi vi vi vi vi vi vi vi vi



section of the Physicians’ Desk Reference (PDR) is most helpful to get information about this
vi vi vi vi vi vi vi vi vi vi vi vi vi vi vi



drug?
vi



a. Manufacturer‟s section vi



b. Brand and Generic Name section vi vi vi vi



c. Product Category section vi vi



d. Product Information section vi vi




ANS: v i B
A physician‟s order would include the brand and/or generic name of the drug. The alphabetic
vi vi vi vi vi vi vi vi vi vi vi vi vi vi



index in the PDR would make this section the most user friendly. Based on a physician‟s
vi vi vi vi vi vi vi vi vi vi vi vi vi vi vi vi



order, manufacturer‟s information and classification information would not be known. The
vi vi vi vi vi vi vi vi vi vi vi



Manufacturer‟s section is a roster of manufacturers. The Product Category section lists
vi vi vi vi vi vi vi vi vi vi vi vi



products subdivided by therapeutic classes, such as analgesics, laxatives, oxytocics, and
vi vi vi vi vi vi vi vi vi vi vi



antibiotics. The Product Information section contains reprints of the package inserts for the
vi vi vi vi vi vi vi vi vi vi vi vi vi



major products of manufacturers.
vi vi vi vi




DIF: Cognitive Level: Comprehension REF: p. 3 OBJ: vi vi v i vi



v 4 TOP: Nursing Process Step: Planning
i vi v i vi vi vi



MSC: NCLEX Client Needs Category: Physiological Integrity
v i vi vi vi vi vi




5. Which online drug reference makes available to health care providers and the public a
vi vi vi vi vi vi vi vi vi vi vi vi vi



vi standard, comprehensive, up to date look up and downloadable resource about medicines?
vi vi vi vi vi vi vi vi vi vi vi



a. American Drug Index vi vi



b. American Hospital Formulary vi vi



c. DailyMed
d. Physicians’ Desk Reference (PDR) vi vi vi




ANS: v i C
DailyMed makes available to health care providers and the public a standard, comprehensive,
vi vi vi vi vi vi vi vi vi vi vi vi



up to date look up and downloadable resource about medicines. The American Drug Index is
vi vi vi vi vi vi vi vi vi vi vi vi vi vi vi



not appropriate for patient use. The American Hospital Formulary is not appropriate for
vi vi vi vi vi vi vi vi vi vi vi vi vi



patient use. The PDR is not appropriate for patient use.
vi vi vi vi vi vi vi vi vi vi




DIF: Cognitive Level: Knowledge REF: p. 4 OBJ: vi vi v i vi



v 5 TOP: Nursing Process Step: Implementation
i vi v i vi vi vi



MSC: NCLEX Client Needs Category: Physiological Integrity
v i vi vi vi vi vi




6. Which legislation authorizes the FDA to determine the safety of a drug before its marketing?
vi vi vi vi vi vi vi vi vi vi vi vi vi vi



a. Federal Food, Drug, and Cosmetic Act (1938) vi vi vi vi vi vi



b. Durham Humphrey Amendment (1952) vi vi vi



c. Controlled Substances Act (1970) vi vi vi




19TH EDITION
vi

, d. Kefauver Harris Drug Amendment (1962) vi vi vi vi




ANS: v i A
The Federal Food, Drug, and Cosmetic Act of 1938 authorized the FDA to determine the
vi vi vi vi vi vi vi vi vi vi vi vi vi vi



safety of all drugs before marketing. Later amendments and acts helped tighten FDA control
vi vi vi vi vi vi vi vi vi vi vi vi vi vi



and ensure drug safety. The Durham Humphrey Amendment defines the kinds of drugs that
vi vi vi vi vi vi vi vi vi vi vi vi vi vi



cannot be used safely without medical supervision and restricts their sale to prescription by a
vi vi vi vi vi vi vi vi vi vi vi vi vi vi vi



licensed practitioner. The Controlled Substances Act addresses only controlled substances and
vi vi vi vi vi vi vi vi vi vi vi



their categorization. The Kefauver Harris Drug Amendment ensures drug efficacy and greater
vi vi vi vi vi vi vi vi vi vi vi vi



drug safety. Drug manufacturers are required to prove to the FDA the effectiveness of their
vi vi vi vi vi vi vi vi vi vi vi vi vi vi vi



products before marketing them.
vi vi vi vi




DIF: Cognitive Level: Knowledge REF: p. 4 OBJ: vi vi v i vi



v 8 TOP: Nursing Process Step: Assessment
i vi v i vi vi vi



MSC: NCLEX Client Needs Category: Physiological Integrity
v i vi vi vi vi vi




7. Meperidine (Demerol) is a narcotic with a high potential for physical and psychological
vi vi vi vi vi vi vi vi vi vi vi vi



vi dependency. Under which classification does this drug fall? vi vi vi vi vi vi vi



a. I
b. II
c. III
d. IV
ANS: v i B
Meperidine (Demerol) is a Schedule II drug; it has a high potential for abuse and may lead to
vi vi vi vi vi vi vi vi vi vi vi vi vi vi vi vi vi



severe psychological and physical dependence. Schedule I drugs have high potential for abuse
vi vi vi vi vi vi vi vi vi vi vi vi vi



and no recognized medical use. Schedule III drugs have some potential for abuse. Use may
vi vi vi vi vi vi vi vi vi vi vi vi vi vi vi



lead to low to moderate physical dependence or high psychological dependence. Schedule IV
vi vi vi vi vi vi vi vi vi vi vi vi vi



drugs have low potential for abuse. Use may lead to limited physical or psychological
vi vi vi vi vi vi vi vi vi vi vi vi vi vi



dependence.
vi




DIF: Cognitive Level: Comprehension REF: p. 4 | p. 5 OBJ: vi vi v i vi vi vi vi



v 7 TOP: Nursing Process Step: Assessment
i vi v i vi vi vi



MSC: NCLEX Client Needs Category: Safe, Effective Care Environment
v i vi vi vi vi vi vi vi




8. What would the FDA do to expedite drug development and approval for an outbreak of
vi vi vi vi vi vi vi vi vi vi vi vi vi vi



smallpox, for which there is no known treatment?
vi vi vi vi vi vi vi vi



a. List smallpox as a health orphan disease. vi vi vi vi vi vi



b. Omit the preclinical research phase. vi vi vi vi



c. Extend the clinical research phase. vi vi vi vi



d. Fast track the investigational drug. vi vi vi vi




ANS: v i D
Once the Investigational New Drug Application has been approved, the drug can receive
vi vi vi vi vi vi vi vi vi vi vi vi



highest priority within the agency, which is called fast tracking. A smallpox outbreak would
vi vi vi vi vi vi vi vi vi vi vi vi vi vi



become a priority concern in the world. Orphan diseases are not researched in a priority
vi vi vi vi vi vi vi vi vi vi vi vi vi vi vi



manner. Preclinical research is not omitted. Extending any phase of the research would mean
vi vi vi vi vi vi vi vi vi vi vi vi vi vi



a longer time to develop a vaccine. The FDA must ensure that all phases of the preclinical and
vi vi vi vi vi vi vi vi vi vi vi vi vi vi vi vi vi vi



clinical research phase have been completed in a safe manner.
vi vi vi vi vi vi vi vi vi vi




DIF: Cognitive Level: Knowledge REF: vi vi v i p. 7 vi OBJ:
v 8 TOP: Nursing Process Step: Assessment
i vi v i vi vi vi




19TH EDITION
vi

, MSC: NCLEX Client Needs Category: Safe, Effective Care Environment
v i vi vi vi vi vi vi vi




9. Which statement is true about over the counter (OTC) drugs?
vi vi vi vi vi vi vi vi vi



a. They are not listed in the USP NF. vi vi vi vi vi vi vi



b. A prescription from a health care provider is needed.
vi vi vi vi vi vi vi vi



c. They are sold without a prescription. vi vi vi vi vi



d. They are known only by their brand names. vi vi vi vi vi vi vi




ANS: v i C
OTC medications do not require a prescription. A variety of names, both generic and trade,
vi vi vi vi vi vi vi vi vi vi vi vi vi vi



can be used for individual drugs sold OTC. OTC drugs are listed in the USP NF. Prescription
vi vi vi vi vi vi vi vi vi vi vi vi vi vi vi vi vi



drugs require an order by a health professional who is licensed to prescribe, such as a
vi vi vi vi vi vi vi vi vi vi vi vi vi vi vi vi



physician, nurse practitioner, physician assistant, or dentist.
vi vi vi vi vi vi vi




DIF: Cognitive Level: Comprehension REF: p. 2 OBJ: vi vi v i vi



v 2 TOP: Nursing Process Step: Planning
i vi v i vi vi vi



MSC: NCLEX Client Needs Category: Physiological Integrity
v i vi vi vi vi vi




10. Which is the most authoritative reference for medications that are injected?
vi vi vi vi vi vi vi vi vi vi



a. Physician’s Desk Reference vi vi



b. Handbook on Injectable Drugs vi vi vi



c. DailyMed
d. Handbook of Nonprescription Drugs vi vi vi




ANS: v i B
The Handbook on Injectable Drugs is the most comprehensive reference available on the
vi vi vi vi vi vi vi vi vi vi vi vi



topic of compatibility of injectable drugs. It is a collection of monographs for more than 300
vi vi vi vi vi vi vi vi vi vi vi vi vi vi vi vi



injectable drugs that are listed alphabetically by generic name.
vi vi vi vi vi vi vi vi vi




DIF: Cognitive Level: Comprehension REF: p. 3 OBJ: vi vi v i vi



v 4 TOP: Nursing Process Step: Assessment
i vi v i vi vi vi



MSC: NCLEX Client Needs Category: Physiological Integrity
v i vi vi vi vi vi




11. The nurse is administering Lomotil, a Schedule V drug. Which statement is true about this
vi vi vi vi vi vi vi vi vi vi vi vi vi vi



vi drug‟s classification? vi



a. Abuse potential for this drug is low. vi vi vi vi vi vi



b. Psychological dependency is likely. vi vi vi



c. There is a high potential for abuse. vi vi vi vi vi vi



d. This drug is not a controlled substance. vi vi vi vi vi vi




ANS: v i A
Lomotil, a Schedule V drug, has an abuse potential of limited physical or psychological
vi vi vi vi vi vi vi vi vi vi vi vi vi



dependence liability compared with drugs in Schedule IV. Because abuse potential is low with
vi vi vi vi vi vi vi vi vi vi vi vi vi vi



a Schedule V drug, a prescription may not be required. Psychological dependency is not likely
vi vi vi vi vi vi vi vi vi vi vi vi vi vi vi



with a Schedule V drug. Schedule V drugs are classified as controlled substances.
vi vi vi vi vi vi vi vi vi vi vi vi vi




DIF: Cognitive Level: Knowledge REF: p. 5 OBJ: vi vi v i vi



v 7 TOP: Nursing Process Step: Assessment
i vi v i vi vi vi



MSC: NCLEX Client Needs Category: Physiological Integrity
v i vi vi vi vi vi




12. The nurse is transcribing new orders written for a patient with a substance abuse history.
vi vi vi vi vi vi vi vi vi vi vi vi vi vi



vi Choose the medication ordered that has the greatest risk for abuse.
vi vi vi vi vi vi vi vi vi vi




19TH EDITION
vi